Blink Technologies, Inc.
Developing robust, non-intrusive, eye tracking technologies
18 employees · est. 2018 · Palo Alto, United States
Oculis
Oculis develops eye drops to treat ophthalmic diseases, improving patients' lives worldwide.
75 employees · est. 2017 · Lausanne, Switzerland
Oculis is the older company (2018 vs 2017); Oculis is the larger of the two.
Side-by-Side Comparison
| Metric | Blink Technologies, Inc. | Oculis |
|---|---|---|
| Founded | ||
| Founded | 2018 | 2017 older |
| Headquarters | ||
| Headquarters | Palo Alto, United States | Lausanne, Switzerland |
| Employees | ||
| Employees | 18 | 75 larger |
| Industry | ||
| Industry | AI, Big Data, Computer Vision | Biotechnology, Health Care, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Series A | Post Ipo Equity |
| Total Funding | ||
| Total Funding | $21.76M | $345.73M |
| Funding Rounds | ||
| Funding Rounds | 3 | 13 |
| Services | ||
| Services | Not tracked yet | Development of ophthalmic and neuro-ophthalmic treatments, Innovative pipeline and clinical trials, Transformative patient-centric solutions |
| Target Customers | ||
| Target Customers | Not tracked yet | Patients with diabetic macular edema, Patients with dry eye disease, Patients with optic neuritis, Medical professionals in ophthalmology and neuro-ophthalmology |
| Taxonomy | ||
| Taxonomy | Eye Tracking Technology, Smart Devices, AI Assistants, Start-up Company, Non-intrusive Technology, Passive Eye Tracking, Hardware-free Technology | Biopharmaceutical Company, Ophthalmic Diseases, Drug Delivery Platform, Diabetic Macular Edema, Cataract Surgery Inflammation, Dry Eye Disease, Anterior Uveitis, Acute Optic Neuritis, Topical Eye Drops, Neuroprotection, Anti-TNFα Biologics, Non-invasive Treatments, Innovative Product Pipeline, Ophthalmology Innovation, International Healthcare Investors |
| Website | ||
| Website | blinkeye.com | oculis.com |
About Blink Technologies, Inc.
Blink Technologies, Inc. is a start-up company established in 2017, with the slogan "Developing robust, non-intrusive, eye tracking technologies." The company is focused on developing eye tracking technology that is set to become a standard feature in our evolving world, reshaping the way we interac...
About Oculis
Oculis, founded in 2017, is a global biopharmaceutical company, publicly listed as Nasdaq: OCS and XICE: OCS. With headquarters in Switzerland and operations in the U.S. and Iceland, the company is focused on saving sight and enhancing eye care worldwide. Its innovative pipeline features multiple...
Be first to know when either one moves
Funding rounds, hiring surges, leadership changes and stack switches at Blink Technologies, Inc. and Oculis — tracked continuously, sent the day they land.
Funding, hiring, leadership and stack changes at Blink Technologies, In... and Oculis — by email.
Frequently Asked Questions
Compare Blink Technologies, Inc. with someone else
Start typing a company name or domain.